These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3545622

  • 1. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C, Schernthaner G.
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Platelet sensitivity to prostacyclin in diabetes mellitus.
    Pillay PK, Pillay U, Balasubramaniam P, Lee KO.
    Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
    [Abstract] [Full Text] [Related]

  • 4. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H, Hirata T, Sugawara H, Sugai K, Yoda B, Toyota T, Goto Y.
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [Abstract] [Full Text] [Related]

  • 5. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G, Sinzinger H, Silberbauer K, Freyler H, Mühlhauser I, Kaliman J.
    Horm Metab Res Suppl; 1981 Aug; 11():33-43. PubMed ID: 6459282
    [No Abstract] [Full Text] [Related]

  • 6. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage.
    Janka HU, Standl E, Schramm W, Mehnert H.
    Diabetes; 1983 May; 32 Suppl 2():47-51. PubMed ID: 6086025
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG.
    Adv Prostaglandin Thromboxane Res; 1980 May; 6():317-20. PubMed ID: 6992529
    [No Abstract] [Full Text] [Related]

  • 9. Platelet function in male diabetics with and without macrovascular complications.
    Tóth L, Szénási P, Jámbor G, Kammerer L, Romics L.
    Diabetes Res Clin Pract; 1992 Feb; 15(2):143-8. PubMed ID: 1563330
    [Abstract] [Full Text] [Related]

  • 10. Paradoxical platelet behaviour in diabetic ketoacidosis.
    Campbell RR, Foster KJ, Stirling C, Mundy D, Reckless JP.
    Diabet Med; 1986 Mar; 3(2):161-4. PubMed ID: 2951159
    [Abstract] [Full Text] [Related]

  • 11. Decreased sensitivity of platelets to prostacyclin in patients with diabetes mellitus.
    Akai T, Naka K, Okuda K, Takemura T, Fujii S.
    Horm Metab Res; 1983 Nov; 15(11):523-6. PubMed ID: 6360841
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.
    Gerö G, Rákóczi I, Tihanyi K, Oláh J, Demeter J, Gáti I.
    Haemostasis; 1985 Nov; 15(6):377-83. PubMed ID: 3908235
    [Abstract] [Full Text] [Related]

  • 14. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB, Miller OV, Spillers C, Gorman RR.
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The influence of age, sex, and the use of oral contraceptives on the inhibitory effects of endothelial cells and PGI2 (prostacyclin) on platelet function.
    Nordøy A, Svensson B, Haycraft D, Hoak JC, Wiebe D.
    Scand J Haematol; 1978 Sep; 21(3):177-87. PubMed ID: 362511
    [Abstract] [Full Text] [Related]

  • 18. Human prostacyclin platelet receptors in diabetes mellitus.
    Modesti PA, Fortini A, Gensini GF, Vanni D, Prisco D, Abbate R.
    Thromb Res; 1991 Sep 01; 63(5):541-8. PubMed ID: 1755006
    [Abstract] [Full Text] [Related]

  • 19. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM, Forscher CA, Sussman II, Mueller HS.
    Am Heart J; 1985 Jun 01; 109(6):1258-63. PubMed ID: 2988323
    [Abstract] [Full Text] [Related]

  • 20. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K, Löbel P, Steinhagen-Thiessen E.
    Eicosanoids; 1989 Jun 01; 2(1):39-45. PubMed ID: 2483819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.